Shares of Sareum Holdings plc (LON:SAR – Get Free Report) passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 26.03 ($0.32) and traded as low as GBX 14.83 ($0.18). Sareum shares last traded at GBX 16 ($0.20), with a volume of 2,324,149 shares trading hands.
Sareum Price Performance
The company has a market capitalization of £11.57 million, a PE ratio of -320.00 and a beta of -0.69. The company’s fifty day moving average is GBX 26.03 and its 200-day moving average is GBX 49.10.
Sareum Company Profile
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor that is in a Phase 1a clinical trials for the treatment of autoimmune diseases.
See Also
- Five stocks we like better than Sareum
- Do ETFs Pay Dividends? What You Need to Know
- The Charles Schwab Company Can Hit New Highs
- What is Short Interest? How to Use It
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- Stock Market Sectors: What Are They and How Many Are There?
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for Sareum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sareum and related companies with MarketBeat.com's FREE daily email newsletter.